Examkin

Question

Difficulty: MediumPharmacologic Interventions

A 68-year-old woman is admitted to the hospital with a 3-day history of fever, productive cough, and progressive shortness of breath. Medical history is significant for nonvalvular atrial fibrillation, essential hypertension, and major depressive disorder. Her current home medications include apixaban, sotalol, lisinopril, and escitalopram. Her temperature is 38.4°C (101.1°F), blood pressure is 132/82 mmHg, pulse is 88/min, and respirations are 22/min. Pulse oximetry shows 93% on room air. Physical examination reveals bronchial breath sounds and crackles in the right lower lung field. Laboratory studies show a leukocyte count of 14,500/mm³. Serum creatinine is 0.9 mg/dL and electrolytes are within normal limits. A chest radiograph demonstrates a right lower lobe consolidation. An electrocardiogram shows normal sinus rhythm with a QTc interval of 520 ms. The patient is diagnosed with non-severe community-acquired pneumonia requiring inpatient management. Which of the following is the most appropriate empiric pharmacotherapy for this patient's infection?

  1. A
    Ceftriaxone and azithromycin
  2. B
    Levofloxacin
  3. Ceftriaxone and doxycyclineAnswer
  4. D
    Ceftriaxone and clarithromycin
  5. E
    Piperacillin-tazobactam and vancomycin

Answer

The most appropriate pharmacotherapy is the combination of ceftriaxone and doxycycline.
Inpatient, non-severe community-acquired pneumonia (CAP) is typically treated empirically with a beta-lactam (e.g., ceftriaxone) plus a macrolide (e.g., azithromycin), or a respiratory fluoroquinolone (e.g., levofloxacin) alone. However, this patient presents with a severely prolonged QTc interval (520 ms), primarily driven by her current use of sotalol and escitalopram. Macrolides and fluoroquinolones are notorious for causing dose-dependent prolongation of the QT interval. In a patient who already has a significantly prolonged QT interval, prescribing these agents is absolutely contraindicated due to the high risk of triggering Torsades de Pointes, a potentially fatal polymorphic ventricular tachycardia. Doxycycline provides excellent atypical pathogen coverage for CAP and does not prolong the QT interval. Therefore, the combination of ceftriaxone and doxycycline is the safest, guideline-concordant alternative.

Step-by-Step Solution

1
Identify the primary diagnosis and severity.
The patient has inpatient, non-severe community-acquired pneumonia (CAP).
Determining the diagnosis and severity dictates the standard empiric antibiotic pathways.
2
Review the standard antibiotic options for inpatient, non-severe CAP.
Standard options include a beta-lactam plus a macrolide, a beta-lactam plus doxycycline, or respiratory fluoroquinolone monotherapy.
Knowing standard regimens is required before adjusting for patient-specific contraindications.
3
Evaluate the patient's baseline metrics and medication list for potential contraindications or interactions.
The patient has a severely prolonged QTc interval of 520 ms due to home medications (sotalol and escitalopram). She is also on a direct oral anticoagulant (apixaban).
Identifying these risk factors is critical to safely select an antibiotic regimen.
4
Eliminate contraindicated antibiotic regimens based on the patient's risk profile.
Macrolides (azithromycin, clarithromycin) and fluoroquinolones (levofloxacin) must be avoided due to the high risk of Torsades de Pointes. Clarithromycin is also contraindicated due to CYP3A4 inhibition interacting with apixaban.
Avoiding severe adverse drug events is a core component of safe pharmacologic management.
5
Select the safest standard alternative.
Ceftriaxone combined with doxycycline is selected.
This provides necessary coverage for Streptococcus pneumoniae and atypical pathogens without prolonging the QT interval.

Key Concept

In patients with underlying QTc prolongation, macrolides and fluoroquinolones should be avoided for the treatment of community-acquired pneumonia; a beta-lactam combined with doxycycline is the preferred alternative.
Rate this question

Topics

Pharmacologic Interventions

More questions from this topic